SABBY MANAGEMENT, LLC - SECOND SIGHT MED PRODS INC ownership

SECOND SIGHT MED PRODS INC's ticker is EYES and the CUSIP is 81362J209. A total of 47 filers reported holding SECOND SIGHT MED PRODS INC in Q2 2021. The put-call ratio across all filers is 3.20 and the average weighting 0.0%.

Quarter-by-quarter ownership
SABBY MANAGEMENT, LLC ownership history of SECOND SIGHT MED PRODS INC
ValueSharesWeighting
Q4 2021$802,000
-13.9%
491,973
+68.5%
0.12%
-7.1%
Q3 2021$931,000
+7.8%
291,973
+66.9%
0.13%
+3.3%
Q2 2021$864,000
-88.6%
174,900
-81.0%
0.12%
-91.8%
Q1 2021$7,608,000922,1931.48%
Other shareholders
SECOND SIGHT MED PRODS INC shareholders Q2 2021
NameSharesValueWeighting ↓
SABBY MANAGEMENT, LLC 291,973$931,0000.13%
Virtu Financial LLC 43,729$139,0000.01%
Jump Financial, LLC 30,551$97,0000.01%
Hudson Bay Capital Management LP 150,404$480,0000.01%
Paloma Partners Management Co 67,406$215,0000.01%
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC 68,100$217,0000.00%
Tower Research Capital LLC (TRC) 31,568$101,0000.00%
Stratos Wealth Partners, LTD. 15,543$50,0000.00%
OPPENHEIMER & CO INC 23,013$73,0000.00%
Cutler Group LLC / CA 3,931$12,0000.00%
View complete list of SECOND SIGHT MED PRODS INC shareholders